News

Zurich - Unisers has raised a total of 14 million US dollars in seed funding as part of a financing round led by Intel Capital. With this fresh capital injection, the start-up now intends to deliver the first systems featuring its technology to identify contaminations in semiconductor chips.

Schlieren/Vevey - Nestlé is joining forces with the biotech firm EraCal Therapeutics from the Greater Zurich Area. The partners will seek to develop new compounds to facilitate controlled food intake. This would be of benefit to metabolic disease patients.

Schlieren - VirtaMed has launched a new module for meniscus operations on the market. With this surgical simulator, trainee orthopedic doctors can practice various repair techniques.

Lugano/Monterrey/Albuquerque - The United States Department of Energy has provided Synhelion and two partners with funding of 3.2 million US dollars. Using the method of generating process heat by way of concentrated solar energy developed by Synhelion, the partners intend to decarbonize cement production.

Zurich - Zurich is gaining a central biomedical informatics platform that revolutionizes data exhange between hospitals in Zurich with artificial intelligence. The city’s two universities and four hospitals will be linked to the central data management for the Zurich research center by 2025.

Zurich/San Diego - The biotech company Invasight and Eurofins Discovery are developing a preclinical candidate against a protein that causes cancer cell invasion. The supplier’s drug research expertise is to be combined with Invasight’s innovative technology for this.

Wädenswil - Mirai Foods has been successful in cultivating fillet steaks with a thickness of one and a half centimeters and more. The breakthrough was achieved with fibration technology. The startup has also gained a new investor in Angst AG Zürich.

Schlieren/Daejeon - The biotech company Elthera has licensed a monoclonal antibody to LegoChem Biosciences Inc. The South Korean company will use this to develop and market an innovative antibody and active substance conjugate for the treatment of several types of cancer.

Zurich/Paris - The French power grid operator RTE has been testing the autonomous inspection solution developed by ANYbotics. To this end, the ANYmal robot recorded thermal, visual, acoustic and frequency data in real time at selected installation. The aim here is to prevent system failures.